new
   Indications for Clofazimine
501
Oct 30, 2025

Clofazimine is an antimycobacterial agent. Since its approval in the United States in 1986, it has been mainly used for the treatment of leprosy and its complications.

Indications for Clofazimine

Treatment of Leprosy

Lepromatous Leprosy: Including dapsone-sensitive lepromatous leprosy, dapsone-resistant lepromatous leprosy, and lepromatous leprosy accompanied by erythema nodosum reactions.

Principle of Combined Medication: To prevent drug resistance, clofazimine must be used in combination with other anti-leprosy drugs and should not be used alone for initial treatment.

Dose Adjustment for Special Cases

Dapsone-sensitive type: A daily dose of 100mg is recommended, combined with two other drugs for at least 2 years.

Dapsone-resistant type: Combination with one or more other drugs is required, and the treatment should last for 3 years.

Erythema nodosum reaction: The dose can be increased to 100–200mg per day, but it should be reduced to 100mg per day as soon as possible to lower the risk of adverse reactions.

Dosage Form, Strength and Properties of Clofazimine

Dosage Form and Strength

Clofazimine is available as soft capsules, with each capsule containing 50mg of the active ingredient.

The capsules are brown and spherical, and the contents consist of micronized clofazimine suspended in an oil-wax base.

Chemical Properties

Chemical Name: 3-(p-Chlorophenylamino)-10-(p-chlorophenyl)-2,10-dihydro-2-isopropyliminophenazine.

Molecular Formula and Molecular Weight: C₂₇H₂₂Cl₂N₄, with a molecular weight of 473.4.

Solubility: It is easily soluble in benzene and chloroform, poorly soluble in water, and slightly soluble in methanol and ethanol.

Excipient Ingredients

The capsule shell contains sodium ethyl parahydroxybenzoate, sodium propyl parahydroxybenzoate, gelatin, etc. The contents include inactive ingredients such as beeswax, lecithin, and vegetable oils.

Storage Methods for Clofazimine

Storage Conditions

Temperature Requirement: It should be stored below 25°C (77°F) to avoid exposure to high temperatures.

Moisture-proof Measure: It must be placed in a sealed container to prevent moisture from affecting the stability of the drug.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Side Effects of Enasidenib

Enasidenib is a targeted therapy for adult patients with relapsed or refractory acute myeloid leukemia (AML)...

Tuesday, December 23rd, 2025, 10:24
What are the Precautions for Enasidenib Administration?

Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor that offers a targeted treatment option for patients...

Tuesday, December 23rd, 2025, 10:21
Dosage and Administration, Recommended Dose of Enasidenib

As an isocitrate dehydrogenase-2 (IDH2) inhibitor, Enasidenib offers a targeted treatment option for patients with...

Tuesday, December 23rd, 2025, 10:09
What Are the Indications for Enasidenib?

Enasidenib is an oral isocitrate dehydrogenase-2 (IDH2) inhibitor, which was first approved for marketing in the...

Tuesday, December 23rd, 2025, 09:30
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved